hVIVO

H1 trading statement

  • Jul 17 2024, 07:10 IST/BST
  • Colin Grant
  • Company Report
  • 6 page(s)
  • Sectors : Pharma and healthcare
  • Companies : hVIVO

Ratings and price correct at time of issue.

  • hVIVO

    Closing Price: 28.0p

  • RATING 11/10/23

  • PREVIOUS RATING 17/02/20

    UNDER REVIEW

Person's Name

Colin Grant

Analyst

DAVY VIEW

hVIVO has issued a trading statement for H1 2024 ahead of its Capital Markets Day later today. Revenue guidance for 2024 is unchanged and is H1 weighted. EBITDA margins are stronger than expected and will drive upgrades to EBITDA forecasts. The business will be supported by the new facilities in Canary Wharf.

View full article

Download full report with analyst certification and important disclosures

Jul 17 2024, 07:10 IST/BST

Download